0001209191-18-003469.txt : 20180112
0001209191-18-003469.hdr.sgml : 20180112
20180112181500
ACCESSION NUMBER: 0001209191-18-003469
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180110
FILED AS OF DATE: 20180112
DATE AS OF CHANGE: 20180112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STACK DAVID M
CENTRAL INDEX KEY: 0001204788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35060
FILM NUMBER: 18526822
MAIL ADDRESS:
STREET 1: THE MEDICINES CO
STREET 2: 8 CAMPUS DRIVE
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pacira Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001396814
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510619477
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 SYLVAN WAY
STREET 2: SUITE 300
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-254-3560
MAIL ADDRESS:
STREET 1: 5 SYLVAN WAY
STREET 2: SUITE 300
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: PACIRA INC
DATE OF NAME CHANGE: 20080318
FORMER COMPANY:
FORMER CONFORMED NAME: Blue Acquisition Corp
DATE OF NAME CHANGE: 20070418
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-10
0
0001396814
Pacira Pharmaceuticals, Inc.
PCRX
0001204788
STACK DAVID M
C/O PACIRA PHARMACEUTICALS, INC.
5 SYLVAN WAY, SUITE 300
PARSIPPANY
NJ
07054
1
1
0
0
CEO and Chairman
Common Stock
2018-01-10
4
M
0
28885
1.61
A
129331
D
Common Stock
2018-01-10
4
S
0
23372
39.96
D
105959
D
Common Stock
2018-01-10
4
S
0
4628
41.03
D
101331
D
Common Stock
2018-01-10
4
S
0
885
41.97
D
100446
D
Common Stock
18596
I
By Stack Schroon Mohawk FLP
Common Stock
1208
I
By LCK Investment LLC
Stock Option (Right to Buy)
1.61
2018-01-10
4
M
0
28885
0.00
D
2020-09-02
Common Stock
28885
83190
D
The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Includes 167 shares of common stock acquired under the issuer's employee stock purchase plan in December 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.625 to $40.60, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.65 to $41.55, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.70 to $42.25, inclusive.
Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.
The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months.
/s/ Kristen Williams, Attorney-in-Fact
2018-01-12